ALPINE IMMUNE SCIENCES, INC. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

2017-01-03: Reporting owner Rodman David Malcom; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
2016-10-03: Reporting owner Rodman David Malcom; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
2016-07-01: Reporting owner Rodman David Malcom; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
2016-04-22: Reporting owner Rodman David Malcom; Form 3; Security Restricted Stock Units; Transaction Holding.

All rows

Transaction date	Reporting owner	Form	Security	Transaction	Shares	Price	Filing
2017-01-03	Rodman David Malcom Officer (Exec Vice President and CMO)	4	Restricted Stock Units Derivative · Direct	M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	−18,056 162,501 owned after	$0.00	2017-01-05
2016-10-03	Rodman David Malcom Officer (Exec Vice President and CMO)	4	Restricted Stock Units Derivative · Direct	M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	−18,056 180,556 owned after	$0.00	2016-10-05
2016-07-01	Rodman David Malcom Officer (Exec Vice President and CMO)	4	Restricted Stock Units Derivative · Direct	M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	−18,055 198,612 owned after	$0.00	2016-07-06
2016-04-22 holding as of filing	Rodman David Malcom Officer (See Remarks)	3	Restricted Stock Units Derivative · Direct	Holding		no price filed	2016-04-22